These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 26497813

  • 21. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    Puijk RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, Scheffer HJ, Nielsen K, de Jong MC, de Vries JJJ, Zonderhuis BM, Eker HH, Kazemier G, Verheul H, van der Meijs BB, van Dam L, Sorgedrager N, Coupé VMH, van den Tol PMP, Meijerink MR, COLLISION Trial Group.
    BMC Cancer; 2018 Aug 15; 18(1):821. PubMed ID: 30111304
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of a robotic system for irreversible electroporation (IRE) of malignant liver tumors: initial results.
    Beyer LP, Pregler B, Michalik K, Niessen C, Dollinger M, Müller M, Schlitt HJ, Stroszczynski C, Wiggermann P.
    Int J Comput Assist Radiol Surg; 2017 May 15; 12(5):803-809. PubMed ID: 27653615
    [Abstract] [Full Text] [Related]

  • 23. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
    Kingham TP, Karkar AM, D'Angelica MI, Allen PJ, Dematteo RP, Getrajdman GI, Sofocleous CT, Solomon SB, Jarnagin WR, Fong Y.
    J Am Coll Surg; 2012 Sep 15; 215(3):379-87. PubMed ID: 22704820
    [Abstract] [Full Text] [Related]

  • 24. 18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.
    Samim M, Prevoo W, de Wit-van der Veen BJ, Kuhlmann KF, Ruers T, van Hillegersberg R, van den Bosch MAAJ, Verkooijen HM, Lam MGEH, Stokkel MPM.
    Eur J Nucl Med Mol Imaging; 2017 Jul 15; 44(7):1165-1175. PubMed ID: 28180965
    [Abstract] [Full Text] [Related]

  • 25. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
    Wendler JJ, Ricke J, Pech M, Fischbach F, Jürgens J, Siedentopf S, Roessner A, Porsch M, Baumunk D, Schostak M, Köllermann J, Liehr UB.
    Cardiovasc Intervent Radiol; 2016 Feb 15; 39(2):239-50. PubMed ID: 26341653
    [Abstract] [Full Text] [Related]

  • 26. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
    van Tilborg AA, Scheffer HJ, de Jong MC, Vroomen LG, Nielsen K, van Kuijk C, van den Tol PM, Meijerink MR.
    Cardiovasc Intervent Radiol; 2016 Oct 15; 39(10):1438-46. PubMed ID: 27387188
    [Abstract] [Full Text] [Related]

  • 27. Computer planned, image-guided combined resection and ablation for bilobar colorectal liver metastases.
    Banz VM, Baechtold M, Weber S, Peterhans M, Inderbitzin D, Candinas D.
    World J Gastroenterol; 2014 Oct 28; 20(40):14992-6. PubMed ID: 25356061
    [Abstract] [Full Text] [Related]

  • 28. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
    Melenhorst MC, Scheffer HJ, Vroomen LG, Kazemier G, van den Tol MP, Meijerink MR.
    Cardiovasc Intervent Radiol; 2016 Jan 28; 39(1):117-21. PubMed ID: 25994516
    [Abstract] [Full Text] [Related]

  • 29. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
    Nieuwenhuizen S, Dijkstra M, Puijk RS, Geboers B, Ruarus AH, Schouten EA, Nielsen K, de Vries JJJ, Bruynzeel AME, Scheffer HJ, van den Tol MP, Haasbeek CJA, Meijerink MR.
    Curr Oncol Rep; 2022 Jun 28; 24(6):793-808. PubMed ID: 35298796
    [Abstract] [Full Text] [Related]

  • 30. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP.
    Arch Surg; 2012 Nov 28; 147(11):1053-61. PubMed ID: 23165618
    [Abstract] [Full Text] [Related]

  • 31. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F, Lutter A, Schnapauff D, Hildebrandt B, Puhl G, Denecke T, Wust P, Gebauer B.
    Rofo; 2014 Jun 28; 186(6):606-12. PubMed ID: 24407711
    [Abstract] [Full Text] [Related]

  • 32. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.
    Vroomen LGPH, Scheffer HJ, Melenhorst MCAM, de Jong MC, van den Bergh JE, van Kuijk C, van Delft F, Kazemier G, Meijerink MR.
    Eur Radiol; 2017 Jun 28; 27(6):2521-2531. PubMed ID: 27659702
    [Abstract] [Full Text] [Related]

  • 33. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.
    Sugimoto K, Moriyasu F, Kobayashi Y, Saito K, Takeuchi H, Ogawa S, Ando M, Sano T, Mori T, Furuichi Y, Nakamura I.
    Jpn J Radiol; 2015 Jul 28; 33(7):424-32. PubMed ID: 26032929
    [Abstract] [Full Text] [Related]

  • 34. Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
    Denecke T, Steffen I, Hildebrandt B, Rühl R, Streitparth F, Lehmkuhl L, Langrehr J, Ricke J, Amthauer H, Hänninen EL.
    Acta Radiol; 2007 Oct 28; 48(8):821-30. PubMed ID: 17924212
    [Abstract] [Full Text] [Related]

  • 35. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
    Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AA, Vieveen JM, Bouwman AR, Meijer S, van Kuijk C, van den Tol PM, Meijerink MR.
    J Vasc Interv Radiol; 2014 Jul 28; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
    [Abstract] [Full Text] [Related]

  • 36. Real-Time US-18FDG-PET/CT Image Fusion for Guidance of Thermal Ablation of 18FDG-PET-Positive Liver Metastases: The Added Value of Contrast Enhancement.
    Mauri G, Gennaro N, De Beni S, Ierace T, Goldberg SN, Rodari M, Solbiati LA.
    Cardiovasc Intervent Radiol; 2019 Jan 28; 42(1):60-68. PubMed ID: 30288593
    [Abstract] [Full Text] [Related]

  • 37. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
    Savic LJ, Chapiro J, Hamm B, Gebauer B, Collettini F.
    Rofo; 2016 Aug 28; 188(8):735-45. PubMed ID: 27074423
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
    Bhutiani N, Philips P, Scoggins CR, McMasters KM, Potts MH, Martin RC.
    HPB (Oxford); 2016 Jul 28; 18(7):593-9. PubMed ID: 27346140
    [Abstract] [Full Text] [Related]

  • 39. Irreversible electroporation in eradication of rabbit VX2 liver tumor.
    Lee EW, Wong D, Tafti BA, Prieto V, Totonchy M, Hilton J, Dry S, Cho S, Loh CT, Kee ST.
    J Vasc Interv Radiol; 2012 Jun 28; 23(6):833-40. PubMed ID: 22534357
    [Abstract] [Full Text] [Related]

  • 40. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M, Beyer LP, Haimerl M, Niessen C, Jung EM, Zeman F, Stroszczynski C, Wiggermann P.
    Diagn Interv Radiol; 2015 Jun 28; 21(6):471-5. PubMed ID: 26359870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.